Literature DB >> 9778274

Central nervous system nitric oxide formation in cerebral systemic lupus erythematosus.

L Brundin1, E Svenungsson, E Morcos, M Andersson, T Olsson, I Lundberg, N P Wiklund.   

Abstract

Systemic lupus erythematosus (SLE) is an inflammatory disease in which up to two thirds of the patients present neurological symptoms. The diagnosis of the disease is based on clinical findings and the presence of autoantibodies, and the pathogenesis is unclear. The purpose of this study was to determine if the pathogenesis was partly mediated via nitric oxide (NO) formation. Cerebrospinal fluid (CSF) samples from 15 patients with cerebral SLE were analyzed for the NO metabolites nitrite and nitrate using capillary electrophoresis. The severity of neurological symptoms was scored by dividing the patients into two groups with either mild or moderate/severe CNS involvement. All patients with cerebral SLE showed increased levels of NO metabolites. In CSF, there was a relationship between signs of NO production and clinical results showing that increased levels of nitrite and nitrate were associated with more severe neurological symptoms. These findings may shed new light on the pathogenesis of cerebral SLE, and analysis of nitrate and nitrate may prove to be of value in monitoring the activity of the disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9778274     DOI: 10.1002/ana.410440421

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  10 in total

Review 1.  Bioanalytical profile of the L-arginine/nitric oxide pathway and its evaluation by capillary electrophoresis.

Authors:  Dmitri Y Boudko
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-02-15       Impact factor: 3.205

2.  Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus.

Authors:  E Svenungsson; M Andersson; L Brundin; R van Vollenhoven; M Khademi; A Tarkowski; D Greitz; M Dahlström; I Lundberg; L Klareskog; T Olsson
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

Review 3.  Role of nitric oxide in cluster headache.

Authors:  Anna Steinberg; A Ingela M Nilsson Remahl
Journal:  Curr Pain Headache Rep       Date:  2012-04

4.  No signs of immunoactivation in the cerebrospinal fluid during treatment with infliximab.

Authors:  M Andersson; E Svenungsson; M Khademi; J Lampa; L Brundin; E Wallström
Journal:  Ann Rheum Dis       Date:  2006-04-10       Impact factor: 19.103

5.  [Primary headaches and the influence of inflammatory diseases of the CNS and their respective immunmodulatory therapy].

Authors:  M Empl; A Straube
Journal:  Schmerz       Date:  2007-10       Impact factor: 1.107

6.  Quercetin induces apoptosis of Trypanosoma brucei gambiense and decreases the proinflammatory response of human macrophages.

Authors:  Maria Mamani-Matsuda; Jérôme Rambert; Denis Malvy; Hélène Lejoly-Boisseau; Sylvie Daulouède; Denis Thiolat; Sara Coves; Pierrette Courtois; Philippe Vincendeau; M Djavad Mossalayi
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

Review 7.  Nitric Oxide as a Target for Phytochemicals in Anti-Neuroinflammatory Prevention Therapy.

Authors:  Lalita Subedi; Bhakta Prasad Gaire; Amna Parveen; Sun-Yeou Kim
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

Review 8.  Update on the pathophysiology of cluster headache: imaging and neuropeptide studies.

Authors:  Alina Buture; Jason W Boland; Lisa Dikomitis; Fayyaz Ahmed
Journal:  J Pain Res       Date:  2019-01-04       Impact factor: 3.133

9.  Two case reports indicating the dilemma in diagnosing lupus cerebritis.

Authors:  Dharitri Goswami; Shuddhosatta Chatterjee; Bashar Imam Ahmad; Shantanu Das
Journal:  J Family Med Prim Care       Date:  2013-01

10.  Nitrated nucleosome levels and neuropsychiatric events in systemic lupus erythematosus; a multi-center retrospective case-control study.

Authors:  Isabel Ferreira; Sara Croca; Maria Gabriella Raimondo; Manjit Matharu; Sarah Miller; Ian Giles; David Isenberg; Yiannis Ioannou; John G Hanly; Murray B Urowitz; Nicole Anderson; Cynthia Aranow; Anca Askanase; Sang-Cheol Bae; Sasha Bernatsky; Ian N Bruce; Jill Buyon; Ann E Clarke; Mary Anne Dooley; Paul Fortin; Ellen Ginzler; Dafna Gladman; Caroline Gordon; Murat Inanc; Søren Jacobsen; Kenneth Kalunian; Diane Kamen; Munther Khamashta; Sam Lim; Susan Manzi; Joan Merrill; Ola Nived; Christine Peschken; Michelle Petri; Rosalind Ramsey-Goldman; Guillermo Ruiz-Irastorza; Jorge Sanchez-Guerrero; Kristjan Steinson; Gunnar K Sturfelt; Ronald van Vollenhoven; Daniel J Wallace; Asad Zoma; Anisur Rahman
Journal:  Arthritis Res Ther       Date:  2017-12-22       Impact factor: 5.156

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.